CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

R Kreutz; J Bolbrinker; F van der Sman-de Beer; E W Boeschoten; F W Dekker; S Kain; P Martus; A Sietmann; F Friedrichs; M Stoll

doi:10.1038/sj.tpj.6500488

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

Identifier:nobleid.org/w1/20260515/9756C2DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9756C2DF.svg?ark=w1%2F20260515%2F9756C2DF)](https://nobleid.org/work/w1/20260515/9756C2DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

R Kreutz

J Bolbrinker

F van der Sman-de Beer

Claim authorship of this work

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.

Identifier:nobleid.org/w1/20260515/9756C2DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9756C2DF.svg?ark=w1%2F20260515%2F9756C2DF)](https://nobleid.org/work/w1/20260515/9756C2DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

R Kreutz

J Bolbrinker

F van der Sman-de Beer

Claim authorship of this work